Phase Ib trial of VTX 1463 in patients with allergic rhinitis.
Phase of Trial: Phase I
Latest Information Update: 21 Mar 2011
At a glance
- Drugs VTX 1463 (Primary)
- Indications Allergic rhinitis
- Focus Proof of concept; Therapeutic Use
- 21 Mar 2011 Results were reported at the Annual Meeting of American Academy of Allergy Asthma and Immunology (AAAAI).
- 07 Oct 2010 Results reported in a VentiRx Pharmaceuticals media release.
- 13 Jan 2010 Status changed from not stated to completed.